Anavex Life Sciences Corp.
AVXL· Nasdaq
AVXLAnavex Life Sciences Corp.
Filed May 14, 2014 · 10-Q · 44 days after period end · 0001062993-14-002934
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$1.02M | -$106.10K | -$910.20K | -$1.97M |
| EPS Diluted | -$0.03 | $0.00 | -$0.03 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Anavex Life Sciences Corp. · CIK 1314052 · Engraved from SEC EDGAR
ended Mar 31, 2014 · filed May 14, 2014 · 44 d after period end
